An Animals Models Core (previously called the Transgenic Core) has been a component of the University of Chicago DRTC since 1991. At the last competitive renewal, the Core was judged to be of outstanding to excellent merit. The Core in this past funding period has supported a large number of mainline diabetes projects including generating transgenic, knockout and knock-in mice and this is reflected in the progress report. The Animal Models Core has continued to evolve and incorporated new services besides generating transgenic and knockout mice in response to the need for additional animal models for diabetes-related research. The Core has also added a human ES service to provide advice and training in the use of human ES cells. The overall objective of this Core is to provide cutting-edge technology and know-how in the generation and use of animal models for diabetes research. The specific objectives are: provide advice and training in the use of genetically modified mice for diabetes and diabetes-related research; produce transgenic mice from pronuclear injection through the F1 stage; provide ES cell blastocyte injections and breeding of chimeric mice through the F1 stage; distribute murine ES cells and feeder cells for ES cell culture; rederive non-commercial mice; provide advice and training in the use of human ES cells; provide service and training in the generation of diabetic mouse models (streptozotocin and partial pancreatectomy); provide service and training in islet transplantation into mice (intraportal and renal capsule); provide service and training in the placement of a 'pancreatic window' to view islets in vivo; and distribute NEDH rats and genetically modified mice. Dr. Manami Hara will serve as Director and Dr. Anita Chong will serve as Co-Director.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Comprehensive Center (P60)
Project #
5P60DK020595-35
Application #
8429597
Study Section
Special Emphasis Panel (ZDK1-GRB-S (O1))
Project Start
Project End
2013-02-28
Budget Start
2012-02-01
Budget End
2013-01-31
Support Year
35
Fiscal Year
2012
Total Cost
$149,234
Indirect Cost
$52,013
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Martyn-Nemeth, Pamela; Quinn, Laurie; Menon, Usha et al. (2017) Dietary Profiles of First-Generation South Asian Indian Adolescents in the United States. J Immigr Minor Health 19:309-317
Peek, Clara Bien; Levine, Daniel C; Cedernaes, Jonathan et al. (2017) Circadian Clock Interaction with HIF1? Mediates Oxygenic Metabolism and Anaerobic Glycolysis in Skeletal Muscle. Cell Metab 25:86-92
Graff, Mariaelisa; Emery, Leslie S; Justice, Anne E et al. (2017) Genetic architecture of lipid traits in the Hispanic community health study/study of Latinos. Lipids Health Dis 16:200
Penckofer, Sue; Byrn, Mary; Adams, William et al. (2017) Vitamin D Supplementation Improves Mood in Women with Type 2 Diabetes. J Diabetes Res 2017:8232863
Hon, Jason; Hwang, Michelle S; Charnetzki, Meara A et al. (2017) Kinetic characterization of the inhibition of protein tyrosine phosphatase-1B by Vanadyl (VO2+) chelates. J Biol Inorg Chem 22:1267-1279
Palygin, Oleg; Evans, Louise C; Cowley Jr, Allen W et al. (2017) Acute In Vivo Analysis of ATP Release in Rat Kidneys in Response to Changes of Renal Perfusion Pressure. J Am Heart Assoc 6:
Olehnik, Scott K; Fowler, Jonas L; Avramovich, Gil et al. (2017) Quantitative analysis of intra- and inter-individual variability of human beta-cell mass. Sci Rep 7:16398
Yue, Jiping; Gou, Xuewen; Li, Yuanyuan et al. (2017) Engineered Epidermal Progenitor Cells Can Correct Diet-Induced Obesity and Diabetes. Cell Stem Cell 21:256-263.e4
Porta, Massimo; Toppila, Iiro; Sandholm, Niina et al. (2016) Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes. Diabetes 65:1022-30
Carmody, D; Ladsaria, S S; Buikema, R K et al. (2016) Successful rhIGF1 treatment for over 5 years in a patient with severe insulin resistance due to homozygous insulin receptor mutation. Diabet Med 33:e8-e12

Showing the most recent 10 out of 839 publications